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+e close contact between dogs and humans creates the best bridge for interspecies transmission of antimicrobial-resistant
bacteria. +e surveillance of its resistance including the detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia
coli as indicator bacteria is an important tool to control the use of antimicrobials.+e aim of this research was to evaluate the E. coli
resistance in strains by phenotypic methods, isolated from pet and stray dogs of La Plata city, Argentina. Faecal samples were
collected using rectal swabs from 50 dogs with owners (home dogs�HD) and 50 homeless dogs (stray dogs� SD). +ey were
cultured in 3 MacConkey agar plates, with and without antibiotics (ciprofloxacin and cefotaxime). 197 strains were isolated, of
which only 95 strains were biochemically identified as E. coli, 46 strains were from HD, and 49 were from SD. Antimicrobial
susceptibility was evaluated by the Kirby–Bauer disk diffusion method. +e most prevalent resistance was for tetracycline,
streptomycin, and ampicillin. In both groups, the level of resistance to 3rd generation cephalosporins was high, and there were
multiresistant strains. +ere was a higher level of antimicrobial resistance in strains from SD compared to HD. +ere were 8% of
strains suspected of being ESBLs among samples of HD and 36% of SD. One (2%) of the strains isolated from HD and 11 (22%)
from SD were phenotypically confirmed as ESBL. Pets and stray dogs are a potential source of E. coli antibiotic resistance in
Argentina; therefore, its surveillance must be guaranteed.
1. Introduction
+e role of pets as one of the most important disseminators
of antimicrobial-resistant bacteria has been underestimated
for a long time because the general focus has been aimed at
food-producing animals as the principal source of resistant
bacteria. However, the close contact between pets and
humans creates the best bridge for interspecies transmission
of multidrug-resistant (MDR) bacteria [1].
Dogs and cats which live in the same house with their
owners make contact with the same surfaces and objects, and
these habits increase the chances of antimicrobial resistance
dissemination. Furthermore, veterinary practice evolution
and the increasing sense of social responsibility for the
welfare and health of pets have enhanced their life expec-
tancy, which has increased the number of geriatric patients
that frequently need antimicrobial therapy, since they often
suffer from chronic diseases or immunocompromising
conditions [2].
Antimicrobials are frequently used for therapeutic and
prophylactic purposes, not only in dogs that live in homes
but also in stray dogs. In Argentina, people without pro-
fessional knowledge frequently administrate antimicrobials
to stray dogs because of the unrestricted antibiotic sale and
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the increasing tendency to protect animals [3]. +e inade-
quate use and abusive prescription of antibiotics, the ap-
plication of subtherapeutic doses, the irregularity in the
administration of antimicrobials, and the change in the
social role of dogs among the community nowadays are
important risk factors for antimicrobial resistance selection
and the transference of bacteria with gene resistance de-
terminants. Several studies have proved that antimicrobial-
resistant bacteria could be transferred from dogs to humans
and from humans to dogs [4–6].
In recent years, there has been an important increment
in the number of companion animals in Argentina.
According to a recent study of the Department of Health and
Animal Protection of the Government of Buenos Aires city,
there are between 800000 and one million dogs and cats,
with and without owners.+is means that there is one pet for
every 3 humans [7, 8].
Several resistance microorganisms have been isolated
from healthy and sick pets, such as methicillin-resistant
Staphylococcus aureus (MRSA), methicillin resistance
Staphylococcus pseudintermedius (MRSP), multidrug-resis-
tance Gram-negative bacteria, and extended-spectrum beta-
lactamase (ESBL)/AmpC-producing Enterobacteriaceae
[9, 10]. +e great increase in strains carrying ESBLs in
humans, animals, and their surrounding environments is a
huge problem worldwide. Companion animals would have a
possible role as reservoirs for ESBLs [11].
ESBL genes in Escherichia coli are mainly encoded in
plasmids; nevertheless, there are studies that confirmed
chromosomal integration [12–14]. +ese enzymes have
hydrolytic activity against penicillins, third-generation
cephalosporins (ceftazidime or cefotaxime), and aztreonam,
but not the cephamycins (cefoxitin) or carbapenems, and are
inhibited by beta-lactamase inhibitors as clavulanic acid
[15]. Beta-lactams are possibly the antimicrobials most
widely used not only in human medicine but also in animals
due to the safety, antimicrobial spectrum, availability, and
pharmacokinetic and pharmacodynamic properties [16].
First-generation cephalosporins and amoxicillin with clav-
ulanic acid and penicillin with an aminoglycoside are pre-
scribed routinely in daily veterinary clinic practice. +ird-
generation cephalosporins represent one of a few therapeutic
options to treat bacterial infections of difficult resolution;
therefore, they are critically important drugs.
Enterobacteriaceae are the main producers of ESBL,
particularly Klebsiella pneumoniae and E. coli [17]. Among
the intestinal microbiome, E. coli has a role as an indicator of
resistance because it is one of the most widespread groups of
intestinal bacteria. +e surveillance of its resistance mech-
anisms is an important tool in the control of nonprudent use
of antimicrobials. It allows us to know which antimicrobials
are selected for antimicrobial resistance, avoiding public
health risks, reducing therapeutic failures and economic
losses among producers [5].
Furthermore, ESBL strains often carry antimicrobial
resistance genes for other antibiotics, such as fluo-
roquinolones, aminoglycosides, tetracyclines, sulfamethox-
azole-trimethoprim, and chloramphenicol. Consequently,
there is a potential risk of cross-resistance mediated by
plasmids, and there is a great concern because of the in-
creasing emergence of different phenotypes of resistance
such as multidrug resistance (MDR: when at least one agent
in three or more families of antibiotics is not sensitive),
extreme resistance (XDR) when they are not sensitive to at
least one agent in all categories of antibacterial families
except one or two of them), and pan-resistance (PDR: when
they are not sensitive to any of the agents in all the anti-
microbial categories) [18, 19].
+e objectives of this research were to detect resistance
patterns and in vitro ESBLs producing E. coli strains by
phenotypic methods, isolated from dogs with owners and
stray dogs of La Plata city, Buenos Aires, Argentina.
2. Materials and Methods
2.1. Bacterial Strains. 50 faecal samples of dogs living in
houses with owners (home dogs �HD) and 50 samples of
homeless dogs (stray dogs � SD) were collected from
October to December 2016 in La Plata city, Buenos Aires,
Argentina. Dogs with owners were clinically healthy,
adults, and raised in family homes. +ey did not receive
antimicrobial treatments in the last 3 months. For
samples taken in a veterinary clinic, only those animals
that come for routine health control or to reinforce
vaccines by the health plan were selected. Stray dog faecal
samples were collected in different areas of La Plata city
following the spiral sampling method [20]. La Plata city is
characterized by its particular design because it is a grid, a
perfect square with two diagonals that cross the complete
city from east to west and from north to south. Conse-
quently, stray dogs were sampled beginning from the
peripheral area to the centre of the square. Only non-
aggressive stray dogs were chosen for sampling since no
sedation method was used. Animals were restrained by
two operators, and a third person took the rectal faecal
sample using a sterile cotton swab.
+e protocol was carried out according to the Guide for
the Care and Use of Agricultural Animals in Agricultural
Research and Teaching (Federation of Animal Science
Societies–FASS-) [21] and was approved by the Experi-
mental Ethics Committee of the Faculty of Veterinary
Science, UNLP, Argentina (47.3.15 J).
In the laboratory, each cotton swab was used to in-
oculate each sample onto 3 agar plates: MacConkey agar
(Difco, Becton Dickinson, USA) supplemented with
2mg/L cefotaxime (plate A), MacConkey agar supple-
mented with 0.05 mg/L ciprofloxacin (plate B) to select
possible resistant strains present in the samples, and the
third plate without antimicrobial (plate C). Cefotaxime
and ciprofloxacin were obtained from Sigma-Aldrich,
MO, USA. After overnight incubation at 37°C, 2-3 col-
onies with the phenotypic characteristics of E. coli were
selected, Gram stained, and typified by biochemical tests
(Urease production, Catalase test, Motility, Voges
Proskauer, Indole production, Carbohydrate fermenta-
tion tests, Methyl red, and Citrate utilization). E. coli
ATCC 25922® (American Type Culture Collection, USA)
was used as quality control [22, 23].
2 International Journal of Microbiology
2.2. Susceptibility Testing. +e strains that grew in plates A
and/or B were identified biochemically as E. coli and tested
for antimicrobial susceptibility by the standard Kirby-Bauer
disk diffusion method. But when there were no colonies on
those plates (A or B) but in C, strains developed in this last
plate without antibiotic were isolated to study. Twenty
antimicrobials (Becton Dickinson, USA) were selected:
amoxicillin/clavulanic acid (20 μg/10 μg), ampicillin (10 μg),
ampicillin-sulbactam (10 μg/10 μg), ceftriaxone (30 μg),
ceftazidime (30 μg), cefotaxime (30 μg), cefazoline (30 μg),
cefpodoxime (10 μg), sulfamethoxazole-trimethoprim
(23.75 μg/1.25 μg), chloramphenicol (30 μg), ciprofloxacin
(5 μg), nalidixic acid (30 μg), tetracycline (30 μg), gentamicin
(10 μg), streptomycin (10 μg), kanamycin (30 μg), amikacin
(30 μg), nitrofurantoin (30 μg), aztreonam (30 μg), and
imipenem (10 μg), according to the Clinical and Laboratory
Standards Institute, CLSI [22, 23].
2.3. ESBL Identification. +e first ESBL disc screening test
was evaluated using antibiotic discs of cefpodoxime, cefta-
zidime, aztreonam, cefotaxime, and ceftriaxone on Mueller
Hinton agar (Britania, Argentine) [18, 19]. Results were
interpreted according to CLSI screening cut-off values for
the antimicrobials mentioned above. When the diameter
around one of the disks mentioned was cefpodoxime
≤17mm, ceftazidime ≤22mm, cefotaxime ≤27mm, cef-
triaxone ≤25mm, aztreonam ≤27mm, respectively, the
isolations were considered suspected of ESBL phenotype
[22, 23].
For the ESBL confirmation, the Double-Disc Synergy
Test was applied according to CLSI 2013; discs containing
ceftazidime and cefpodoxime were put next to a disc with
amoxicillin plus clavulanic acid (20mm centre to centre).
+e positive result is indicated when the inhibition zones
around any of the cephalosporin discs were augmented in
the direction of the disc containing clavulanic acid. E. coli
ATCC 25922® was used for quality control [22, 23].
2.4. Statistical Analysis. Chi-square test was used to deter-
mine the significance of differences in resistance prevalence
between stray dogs and pets. A value of p≤ 0.05 was con-
sidered significant.
3. Results and Discussion
197 strains were isolated (77 from HD and 120 from SD)
from the 100 faecal samples. Only 95 strains biochemically
identified as E. coli (46 from HD and 49 from SD) were
studied; every strain was individual and becomes from one
of the 3 plates mentioned above (A, B, or C). From a few
samples, we obtained isolations biochemically identified as
E. coli from both plates A and B at the same time, but we
studied them individually. +ey were chosen as follows:
from samples of HD, 3 strains of E. coli grew on plate A (with
cefotaxime), 19 grew on plate B (with ciprofloxacin), and the
rest of the strains (n� 24) only developed on agar without
antimicrobials; on the other hand, from samples of SD, 19
strains of E. coli developed on plate A and 16 on plate B; the
rest (n� 14) grew in the plates without antimicrobials (plate
C).
+ose strains that had grown on agar with cefotaxime
(plate A) or with ciprofloxacin (plate B) were selected to
carry out antibiograms. Strains of E. coli that were inhibited
in plates A and B but developed in plate C without anti-
microbial were the third group studied, including suscep-
tibility test.+erefore, a total of 46 strains of dogs with owner
and 49 without owner were selected for the study.
+e most common resistance observed was to tetracy-
cline (70%) in SD-derived strains and to nalidixic acid
(38.3%) in HD-derived strains. Resistance to streptomycin
(46%) and ampicillin (44%) was the second high in SD
strains. For HD, there were 25.5% of resistance to ampicillin
and 19.1% to sulfamethoxazole-trimethoprim. In both
groups, the level of resistance to 3rd generation cephalo-
sporins was high (ceftriaxone: 30% SD–21.3% HD and
cefotaxime: 28% for SD). +ere was a higher level of anti-
microbial resistance in strains from SD compared to HD. No
E. coli from either group showed resistance to imipenem or
nitrofurantoin. +ere were multiresistant strains in both
groups, and their resistance profile includes one, two, three,
and more than four antimicrobials (see Figure 1 and
Table 1).
+ere were 8% of strains suspected of being ESBL among
samples of HD and 36% of SD. One of the suspected ESBL
strains from HD (2%) and 11 (22%) of SD were confirmed.
+e most prevalent phenotypes of resistance detected
among the E. coli isolates recovered from HD were nalidixic
acid (NAL� 5 isolates) and nalidixic acid with tetracycline
(NAL+TET� two isolates).
+e multiresistance occurrence was considerably higher
in SD strains, with 32.7% of MDR profiles to more than 4
antimicrobials. +e most prevalent phenotypes detected for
SD isolates were tetracycline (TET� 8 isolates), and as HD
strains, nalidixic acid with tetracycline (NAL+TET� three
isolates).
All the strains that showed resistance to 4 antimicrobials
or more in both groups (HD and SD strains) belong to
isolates that had previously developed in plates with anti-
microbial (ciprofloxacin and cefotaxime) (see Tables 2 and
3).
In our study, samples were obtained from faeces of
animals with and without owners, but they were not clinical
samples because the principal aim of our work was to know
the prevalence of antimicrobial resistance in E. coli as in-
dicator bacteria in La Plata city, in dogs without recent
antimicrobial therapy. Most authors have published results
obtained from clinical samples such as urine, urinary tract,
intestinal tract, and ears [24–26]. +is makes it difficult to
compare results since there is an expected difference in the
prevalence of resistance between populations of sick and
healthy dogs.
Resistance to antimicrobials in the present study
appeared to be higher than those previously reported in
other studies done with healthy dogs. +e highest level of
resistance obtained was for tetracycline in SD-derived
strains but not in pets (p< 0.0001). Ampicillin was the
second most prevalent resistance observed (SD� 44%;
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HD� 25.5%); however, it was not quite significant
(p � 0.8888). Resistance to nalidixic acid was common in
both groups of animals (HD� 38.3%; SD� 44%), considered
not significant (p � 0.6798). Stray dog isolates also showed
high resistance against streptomycin (46%), but it was low
(17%) in pets (p< 0.0001). Resistance to ampicillin and
tetracycline is the most frequently reported in most studies
made with healthy dogs, in different countries [27–29]. +e
resistance percentages obtained for the antimicrobials
mentioned above in pet strains (HD) are similar to those
reported in a study of Wedley et al. [27], from healthy dogs
living in a semirural community in Cheshire, UK (24% for
ampicillin and 19.7% for tetracycline). In another study
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Figure 1: Antimicrobial resistance percentages in home dog and stray dog strains. TET (tetracycline), AMP (ampicillin), STR (strep-
tomycin), STX (sulfamethoxazole-trimethoprim), CRO (ceftriaxone), CFZ (cefazolin), CPD (cefpodoxime), CAZ (ceftazidime), CTX
(cefotaxime), ATM (aztreonam), NAL (nalidixic acid), CIP (ciprofloxacin), SAM (ampicillin-sulbactam), AMC (amoxicillin-clavulanic
acid), CHL (chloramphenicol), GEN (gentamicin), KAN (kanamycin), IMP (imipenem), AMK (amikacin), NIT (nitofuratoin), MDR
(multidrug-resistant).
Table 1: Prevalence of antimicrobial resistance E. coli isolated from pets and stray dogs.
Antimicrobial agents
Antimicrobial-resistant E. coli isolated from
Home dogs (n� 46) Stray dogs (n� 49)
Number Percentage Number Percentage
Tetracyclinea 13 27.7 35 70
Ampicillin 12 25.5 22 44
Streptomycina 8 17 23 46
Sulfamethoxazole-Trimethoprim 9 19.1 5 10
Ceftriaxone 10 21.3 15 30
Cefazolina 5 10.6 18 36
Cefpodoxime 2 4.3 8 16
Ceftazidime 2 4.3 8 16
Cefotaximea 0 0 14 28
Aztreonama 4 6.4 15 30
Nalidixic acid 18 38.3 22 44
Ciprofloxacin 4 8.5 10 20
Ampicillin-sulbactam 6 12.8 12 24
Amoxicillin-clavulanic 2 4.3 4 8
Chloramphenicola 2 4.3 13 26
Gentamicina 0 0 6 12
Kanamycina 1 2.1 7 14
Imipenem 0 0 0 0
Amikacin 0 0 2 4
Nitrofurantoin 0 0 0 0
R 1 ATM 8 17.4 9 18.4
R 2 ATMs 5 10.9 5 10.2
R 3 ATMs 2 4.3 5 10.2
R 4 or more ATMs 11 23.9 23 32.7
ap≤ 0.05; R 1 ATM (resistance to only one antimicrobial); R 2 ATMs (resistance to two antimicrobials only); R 3 ATMs (resistance to three antimicrobials
only); R 4 or more ATMs (resistance to four or more antimicrobials).
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found a higher level of resistance for both antibiotics; 37.2%
of the isolates were resistant to ampicillin and 30% to tet-
racycline [28]. Nevertheless, these results are still lower than
those reported for SD isolates in our work. +e results re-
ported by Costa et al. [30], in healthy pets from Portugal
isolates, were even lower: 20.5% of resistance for tetracy-
clines and 7.7% for ampicillin. Interestingly, in some studies
done with clinical isolates, in the E. coli isolated from urinary
infections, septicaemia, and skin and soft tissue infections,
the resistance to ampicillin and tetracycline was lower than
that of our results [24, 31].
Beta-lactams and tetracyclines are the antimicrobials
more used in pets; the different levels of resistance reported
in every work correlate with the frequency and magnitude of
their use in different countries. Furthermore, our results are
disturbing because they demonstrate that in La Plata it seems
to be an abuse and/or misuse of broad-spectrum antimi-
crobials such as tetracyclines, as well as beta-lactams.
+e identification of ESBLs producing strains is very
important to guide an adequate antimicrobial therapy.+ere
were 8% of strains suspected of being ESBLs among samples
of HD and 36% from SD. One of the ESBL strains suspected
from HD (2%) and 11 (22%) of SD were confirmed by
phenotypic tests, but there was no genetic confirmation,
which is a limitation in our study. Again, the results obtained
for HD strains are similar to those published byWedley et al.
[27, 28], but the percentage of ESBL in SD strains was
considerably higher.
+e prevalence of multidrug resistance (resistance to
more than 3 antimicrobials) was considerably higher in SD
strains, compared to several studies published by other
authors [27, 28, 32–34]. In pet strains (HD), there was a
similar percentage (28%) of MDR to those reported by
Murphy et al. [34], in a study made on healthy dogs from
Canada. Again, the findings in SD strains are a big concern.
Antimicrobials can be acquired without a professional
prescription in Argentina. +is is one of the possible reasons
that lead to the administration of them by anyone, even
without being a veterinarian. Another possible source of
antimicrobial resistance transmission is the garbage; stray
dogs break the garbage bags and eat them. It is possible that
bacteria contained in those bags carry antimicrobial resis-
tance genes. On the other hand, household antibiotic waste
contaminates the nonhome environment, selecting anti-
microbial resistance in bacteria there, which then infect stray
dogs and other humans. In Argentina, data are extremely
limited for the amount of antimicrobial-resistant bacteria on
pets and in the near-home environment. Furthermore,
whilst antimicrobials are monitored in stuff entering the
formal market, there is a significant informal market, and
antimicrobial levels in the environment are not routinely
measured. One potential response to the rising threat of
antimicrobial resistance is regulation, and both international
organizations—led by the WHO—and individual countries
have sought to formulate, for example, new regulatory
frameworks to address the use of antimicrobials, as well as
the household waste management. +e source of the re-
sistance genes in those bacteria of stray dogs is still un-
known, and further studies should be done to detect such
environmental source(s).
One of the most prevalent phenotypes detected for SD
and HD isolates was nalidixic acid with tetracycline
(NAL+TET� three isolates).+ose strains were NALR CIPS;
it means that they were resistant to nalidixic acid and
Table 2: Phenotypes of resistance detected among the E. coli isolates recovered from pets.











SXT+CIP +NAL+TETa 1 2.17
STX+NAL+TET+ STRa 1 2.17
SXT+TET+ STR+AMP+CROa 1 2.17
STX+TET+ STR+AMP+CROa 1 2.17
NA+TET+ STR+AMP+CROa 1 2.17
STX+CFZ+NAL+TET+AMPa 1 2.17
SXT+ SAM+CIP +NAL+TET+AMPa 1 2.17
STX+ SAM+CIP +NAL+TET+ STR+AMPa 1 2.17
STX+ SAM+NAL+TET+AMP+CRO+ATMa 1 2.17
CTX+CFZ+ SAM+CPD+CRO+CIP+NAL+AMP+CROb 1 2.17
CAZ+CTX+AMC+CFZ+ SAM+CIP+CRO+AMP+ATMb 1 2.17
aE. coli developed on the plate with ciprofloxacin; bE. coli developed on the plate with cefotaxime. TET, tetracycline; AMP, ampicillin; STR, streptomycin;
STX, sulfamethoxazole-trimethoprim; CRO, ceftriaxone; CFZ, cefazolin; CPD, cefpodoxime; CAZ, ceftazidime; CTX, cefotaxime; ATM, aztreonam; NAL,
nalidixic acid; CIP, ciprofloxacin; SAM, ampicillin-sulbactam; AMC, amoxicillin-clavulanic acid; GEN, gentamicin; KAN, kanamycin.
International Journal of Microbiology 5
susceptible to ciprofloxacin. +is is a frequent finding in
daily veterinary clinic laboratory. +e mechanisms of re-
sistance to quinolones are target alterations or efflux pump
overexpression. +e most relevant mechanism is the mu-
tation of genes encoding quinolone targets (DNA gyrase and
topoisomerase IV).+emutation on a point of the gyrA gene
is frequently in E. coli clinical strains and has been associated
with this phenotype NALR CIPS. Bacteria that have this kind
of mutation have shown to develop more frequently higher
levels of resistance in the presence of quinolones [35].
4. Conclusions
It is very important to know the prevalence of antimicrobial
resistance by surveillance studies not only in pets but also in
homeless dogs. +e unrestricted antibiotic sale, weak
management of household waste, and the increasing ten-
dency to protect animals in Argentina are important risk
factors for antimicrobial resistance selection and the
transference of gene resistance determinants among bacteria
from pets, homeless dogs, and humans. +e results of the
present study indicate that similar studies in other cities of
Argentina would be very useful for monitoring antimicro-
bial resistance at the national level.
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[35] J. Ruiz, J. Gómez, M. M. Navia et al., “High prevalence of
nalidixic acid resistant, ciprofloxacin susceptible phenotype
among clinical isolates of Escherichia coli and other Enter-
obacteriaceae,” Diagnostic Microbiology and Infectious Dis-
ease, vol. 42, no. 4, pp. 257–261, 2002.
8 International Journal of Microbiology
